[Therapeutic results of H.M. 51 Sandoz (Visergil) in gerontopsychiatry].
D000284:Administration, Oral; D000367:Age Factors; D000368:Aged; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004357:Drug Synergism; D004877:Ergoloid Mesylates / Q000008:administration & dosage / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D006801:Humans; D010919:Placebos; D011618:Psychotic Disorders / Q000188:drug therapy*; D013881:Thioridazine / Q000008:administration & dosage / Q000627:therapeutic use*
D004338:Drug Combinations; D010919:Placebos; D004877:Ergoloid Mesylates; D013881:Thioridazine
Resultados terapéuticos del H.M. 51 Sandoz (Visergil) en gerontopsiquiatria.